ADC Therapeutics (ADCT) EBIT Growth (1y) (2021 - 2026)
ADC Therapeutics (ADCT) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | 11.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.31% |
| Sep 30, 2025 | 12.92% |
| Jun 30, 2025 | -52.02% |
| Mar 31, 2025 | 15.32% |
| Sep 30, 2024 | 1.62% |
| Jun 30, 2024 | 26.75% |
| Mar 31, 2024 | 34.82% |
| Sep 30, 2023 | -1,060.85% |
| Jun 30, 2023 | 42.88% |
| Mar 31, 2023 | -27.77% |
| Dec 31, 2022 | 42.70% |
| Sep 30, 2022 | 94.61% |
| Jun 30, 2022 | 1.52% |
| Mar 31, 2022 | 42.88% |
| Dec 31, 2021 | 52.04% |
| Sep 30, 2021 | -10.23% |
| Jun 30, 2021 | -56.80% |
| Mar 31, 2021 | -61.02% |